These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 19681208)

  • 1. Atrial fibrillation and blood pressure.
    Harv Heart Lett; 2009 Jun; 19(10):6. PubMed ID: 19681208
    [No Abstract]   [Full Text] [Related]  

  • 2. [Atrial fibrillation as endpoint in studies of arterial hypertension].
    Jung J
    Dtsch Med Wochenschr; 2003 Nov; 128(47):2493-6. PubMed ID: 14628258
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypertensive patient with enlarged heart. Caution, risk of atrial fibrillation!].
    MMW Fortschr Med; 2006 May; 148(21):62. PubMed ID: 16796195
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension, stroke and the impact of atrial fibrillation.
    Krishnamoorthy S; Lip GY
    Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1287-9. PubMed ID: 19018678
    [No Abstract]   [Full Text] [Related]  

  • 6. Does treatment of hypertension decrease the incidence of atrial fibrillation and cardioembolic stroke?
    Solun B; Marcoviciu D; Dicker D
    Eur J Intern Med; 2009 Mar; 20(2):125-31. PubMed ID: 19327599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antihypertensive agents on risk of atrial fibrillation: a meta-analysis of large-scale randomized trials.
    Emdin CA; Callender T; Cao J; Rahimi K
    Europace; 2015 May; 17(5):701-10. PubMed ID: 25855678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive systolic blood pressure control and prevention of new onset atrial fibrillation in the SPRINT study: is the association really controversial?
    Kjeldsen SE; Narkiewicz K; Burnier M; Oparil S
    Blood Press; 2020 Aug; 29(4):199-201. PubMed ID: 32584173
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinicians treating hypertension need to mind their "P's" (precision) and "Q's"(quantitation): a lesson from left ventricular hypertrophy regression and atrial fibrillation.
    Giles TD
    J Clin Hypertens (Greenwich); 2007 May; 9(5):314-5. PubMed ID: 17485965
    [No Abstract]   [Full Text] [Related]  

  • 10. A therapeutic opportunity that needs to be optimized.
    Jolobe OM
    Am Heart J; 2012 Oct; 164(4):e11. PubMed ID: 23067924
    [No Abstract]   [Full Text] [Related]  

  • 11. Slower heart rates for healthy hearts: time to redefine tachycardia?
    Gopinathannair R; Sullivan RM; Olshansky B
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):321-3. PubMed ID: 19808425
    [No Abstract]   [Full Text] [Related]  

  • 12. Clevidipine: a novel ultra-short-acting calcium antagonist.
    Prlesi L; Cheng-Lai A
    Cardiol Rev; 2009; 17(3):147-52. PubMed ID: 19384089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure variability reduction and organ protection in hypertension treatment.
    Chen AF
    Hypertens Res; 2008 Apr; 31(4):587-8. PubMed ID: 18633167
    [No Abstract]   [Full Text] [Related]  

  • 14. How drugs act. Twelve. Drugs and hypertension.
    Smith S
    Nurs Times; 1985 Feb 20-26; 81(8):37-9. PubMed ID: 3844805
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of Atrial Fibrillation by Intensive Antihypertensive Treatment.
    Zhang W; Wang JG
    Hypertension; 2020 Jun; 75(6):1414-1416. PubMed ID: 32401649
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological attenuation of blood pressure variability.
    Julien C
    Acta Pharmacol Sin; 2005 Nov; 26(11):1288-9. PubMed ID: 16225748
    [No Abstract]   [Full Text] [Related]  

  • 17. The aorta and resistant hypertension.
    Williams B
    J Am Coll Cardiol; 2009 Feb; 53(5):452-4. PubMed ID: 19179204
    [No Abstract]   [Full Text] [Related]  

  • 18. Agents with antialdosterone properties should be the preferred diuretics for reducing hypertension related atrial fibrillation.
    Jolobe OM
    Eur J Intern Med; 2010 Feb; 21(1):55. PubMed ID: 20122621
    [No Abstract]   [Full Text] [Related]  

  • 19. Atrial Fibrillation and Hypertension.
    Dzeshka MS; Shantsila A; Shantsila E; Lip GYH
    Hypertension; 2017 Nov; 70(5):854-861. PubMed ID: 28893897
    [No Abstract]   [Full Text] [Related]  

  • 20. Confounding factors affecting association of antihypertensive medications and pulse pressure.
    Mody R; Miller LA
    Am J Med; 2004 Nov; 117(9):709-10. PubMed ID: 15501212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.